Dexcel Pharma Technologies Ltd.'s Net Worth
$1.26 Billion
Who is Dexcel Pharma Technologies Ltd.?
Dexcel Pharma Technologies Ltd. has an estimated net worth of $1.26 Billion. This is based on reported shares across multiple companies, which include Roivant Sciences Ltd., Arbutus Biopharma Corp, Myovant Sciences Ltd., Intec Pharma Ltd., Urovant Sciences Ltd., Protalix BioTherapeutics, Inc., and Axovant Sciences Ltd..
SEC CIK
Dexcel Pharma Technologies Ltd.'s CIK is 0001720007
Past Insider Trading and Trends
2022 was Dexcel Pharma Technologies Ltd.'s most active year for acquiring shares with 3 total transactions. Dexcel Pharma Technologies Ltd.'s most active month to acquire stocks was the month of March. 2020 was Dexcel Pharma Technologies Ltd.'s most active year for disposing of shares, totalling 3 transactions. Dexcel Pharma Technologies Ltd.'s most active month to dispose stocks was the month of January. 2022 saw Dexcel Pharma Technologies Ltd. paying a total of $20,154,954.16 for 4,040,285 shares, this is the most they've acquired in one year. In 2021 Dexcel Pharma Technologies Ltd. cashed out on 918,717 shares for a total of $2,088,857.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.05% | 4M |
$5.00 | $20,000,000.00 | 102.85M |
Nov 10
| |||
Form 4
| +0.04% | 40.28K |
$3.85 | $154,954.16 | 98.85M |
Apr 22 - Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intec Pharma Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.78% | -915.95K |
$0.31 | -$281,658.86 | 4.23M |
Jan 31 - Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.04% | 18.2K |
$8.36 | $151,380.99 | 45.71M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.05% | 22.01K |
$8.12 | $177,300.64 | 45.67M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.05% | 21.34K |
$8.22 | $177,247.38 | 45.62M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.05% | 21.12K |
$7.80 | $165,950.15 | 45.58M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.04% | 17.75K |
$7.86 | $138,946.36 | 45.54M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.03% | 14.48K |
$7.65 | $110,461.18 | 45.51M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.02% | 9.84K |
$7.91 | $77,809.93 | 45.49M |
Scheduled
|
May 22 - May 23
| ||
Form 4
| +0.04% | 9.99K |
$8.52 | $85,108.42 | 22.74M |
May 21
| |||
Form 4
| +0.02% | 10K |
$8.19 | $80,524.83 | 45.45M |
May 20
| |||
Form 4
| +0.03% | 11.61K |
$7.08 | $82,359.46 | 45.42M |
May 16 - May 17
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.16% | -918.72K |
$2.27 | -$2,088,857.27 | 3.64M |
Jun 2 - Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||